Abbott Product Materials Sample Clauses

Abbott Product Materials. 20 5.7 Identification of Sepracor on Abbott Product Materials...........20
Sample 1
AutoNDA by SimpleDocs
Abbott Product Materials. In addition to Sepracor Promotional Materials developed and prepared by Sepracor, Abbott may develop, at its expense, Abbott Product Materials, to be used by Abbott in connection with Abbott Promotional Efforts. Prior to distribution to Abbott Representatives or others, Abbott shall give Sepracor the opportunity to review the Abbott Product Materials and make suggestions regarding format and content, and shall not print or distribute any Abbott Product Materials prior to receiving Sepracor's written approval. Sepracor shall use reasonable efforts to review and approve the Abbott Product Materials within thirty (30) days after receipt of proposed Abbott Product Materials. Sepracor shall submit any such Abbott Product Material to FDA, as may be required by law or regulation. In the event of any change to any Product formulation, labeling, or packaging which requires a change in any Abbott Product Materials, after notice from Sepracor of any such change, Abbott shall revise, and receive Sepracor's approval on all such revisions, on all Abbott Product Materials affected by such change before any further distribution of any affected Abbott Product Materials. The cost and expense of modifications to Abbott Product Materials shall be borne by Xxxxxx. Xxxxxx shall retain all rights, including copyrights, to the Abbott Product Materials, except with respect to any Sepracor Marks, which shall remain Sepracor's sole property, free of any claims thereto by Xxxxxx. Xxxxxx shall use any Abbott Product Materials containing the Trademark or Sepracor Marks only in connection with the promotion of the Product to the Pediatric Market in the Territory. Abbott shall have no obligation to pay any royalties or other compensation to Sepracor on the use of the Sepracor Marks used in the Abbott Product Materials. During the Term, Sepracor may use, at its expense, the Abbott Product Materials in connection with Sepracor's promotion of the Product to the Pediatric Market in the Territory. After the Term, Sepracor shall have a royalty-free non-exclusive license to use Abbott Product Materials, exclusive of any Abbott Marks or any other Abbott intellectual property that may appear or is described therein, and to make and use derivative works thereof.
Sample 1

Related to Abbott Product Materials

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Product The term “

  • Regulatory Materials (a) Alvogen shall have the sole right to control filing or submission of Regulatory Materials with the Regulatory Agencies in the Territory with respect to Product including the MAA Approval for Product and Regulatory Approvals in the Territory, subject to Section 3.2 and the oversight of and in consultation with the Executive Steering Committee, and [***]Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. shall be responsible for managing all communications and interactions with the Regulatory Agencies in the Territory with respect to Product in the Territory. In all cases, prior to the filing of any Regulatory Materials (including the MAA for Product) for Product with the applicable Regulatory Agency, Alvogen shall provide a copy thereof to Pfenex (through the Executive Steering Committee) for its review and comment. Pfenex shall have fifteen (15) Business Days from the date it receives a copy of any Regulatory Materials with respect to the Product to provide Alvogen with comments regarding such Regulatory Materials, unless the Regulatory Agencies in the Territory or Applicable Law requires that such Regulatory Material(s) be filed on a timeline that does not reasonably permit such advanced notice, in which case Pfenex shall have as much time as is reasonably practicable to provide Alvogen with comments. Alvogen shall consider all such comments in good faith. Alvogen shall, to the extent permitted by Applicable Law, provide Pfenex with (i) reasonable advanced notice (and in no event less than fifteen (15) Business Days’ advance notice whenever feasible) of substantive meetings with any Regulatory Agency in the Territory that are either scheduled with or initiated by or on behalf of Alvogen or its Affiliates, (ii) an opportunity to have a reasonable number (but at least two (2)) representatives participate in all substantive meetings with the Regulatory Agencies in the Territory with respect to Product, and in any case keep Pfenex informed as to all material interactions with the Regulatory Agencies in the Territory with respect to Product, and (iii) a copy of any material documents, information and correspondence submitted to or received from the Regulatory Agencies in the Territory with respect to Product as soon as reasonably practicable.

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Product Trademarks BMS shall be solely responsible for the selection (including the creation, searching and clearing), registration, maintenance, policing and enforcement of all trademarks developed for use in connection with the marketing, sale or distribution of Products in the Field in the Territory (the “Product Marks”). BMS shall own all Product Marks, and all trademark registrations for said marks.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

Time is Money Join Law Insider Premium to draft better contracts faster.